Patterson Leone D
- SEC CIK
- 0001233539
No open-market purchases or sales filed in the past year.
Current role at each company
- NKTX Nkarta, Inc.Directoras of Jun 11, 2026
- KLRS Kalaris Therapeutics, Inc.Directoras of Jun 4, 2026
- ZYME Zymeworks Inc.EVP, Chief Bus & Fin Officeras of Jan 7, 2026
- TNYA Tenaya Therapeutics, Inc.Chief Fin. and Bus. Officeras of Feb 27, 2024
- CLYM Climb Bio, Inc.Directoras of Jun 1, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Patterson Leone D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TNYA Tenaya Therapeutics, Inc.
Chief Fin. and Bus. Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 16, 2024 (view filing) | Feb 16 | Same day | Patterson Leone DChief Fin. and Bus. Officer | SSale | −5.20K | $5.86 | −$30.5K | −7.9%60.8K after | |
| Aug 18, 2023 (view filing) | Aug 16 | 2 days | Patterson Leone DChief Fin. and Bus. Officer | SSale | −4.45K | $3.81 | −$17.0K | −6.5%64.5K after |